Medibank Private Ltd (ASX: MPL) has seen its share price sink from a 52-week high of $3.32, down to the current price of $2.57.

Still, the private health insurer has seen some small recovery in its share price from a low of $2.06 in December 2015.

The share price plunged in mid-August as the chart below shows, falling from around $3.00 to $2.70, despite reporting a bumper profit.

medibank share price chart

Source: Yahoo Finance

Declining customer numbers, falling market share and existing customers downgrading their insurance cover were all raised as issues.

While CEO Craig Drummond acknowledged these issues, there’s still plenty of work for the insurer to turn around those trends.

At the current price of $2.57, and with earnings per share of 15 cents, Medibank is trading on a P/E ratio of around 17x, and the dividend of 11 cents puts the company on a trailing dividend yield of 4.3% – fully franked.

Analysts are forecasting just a modest rise in earnings next financial year and in FY2018 as well suggesting that the health insurer’s shares are moderately-to-expensively priced. However, some investors may well see this as a buying opportunity.

Foolish takeaway

Despite its higher P/E ratio of 20x, NIB Holdings Limited (ASX: NHF) appears to represent much better value thanks to its better potential future growth.

 

How 1 Man Turned $10,600 Into Over $8 Million

Discover how one man turned a modest $10,600 investment into an $8,016,867 fortune. Learn more about this man and how you can start down the path toward financial independence. Simply click here to learn more. No credit card required.

HOT OFF THE PRESSES: Motley Fool’s #1 Dividend Pick for 2017!

With its shares up 155% in just the last five years, this ‘under the radar’ consumer favourite is both a hot growth stock AND our expert’s #1 dividend pick for 2017. Now we’re pulling back the curtain for you... And all you have to do to discover the name, code and a full analysis is enter your email below!

Simply enter your email now to receive your copy of our brand-new FREE report, “The Motley Fool’s Top Dividend Stock for 2017.”

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our https://www.fool.com.au/financial-services-guide">Financial Services Guide (FSG) for more information.

Motley Fool writer/analyst Mike King doesn't own shares in any companies mentioned. You can follow Mike on Twitter @TMFKinga

The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.